Brown University scholars work to turn breakthroughs and discoveries into technologies that enhance lives, placing the ...

An undeniable off-white and royal blue has crashed the Nike scene, arriving in the form of an Air Jordan 11—specifically the ...

Evoke Pharma shares surged after the company received a notice of allowance for a U.S. patent application for Gimoti extending Orange Book listings to 2036.

Nokia is deeply undervalued, with strong fundamentals, a robust balance sheet, and significant upside potential. Click here ...

Hims & Hers Health, Inc. (HIMS) announced on Wednesday that it will expand to Canada next year with its weight loss program, ...

Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my ...

A new patent granted to Apple reveals that a next-gen Apple Pencil could work with your iPhone, but also many other devices.

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda. Prosecutors Question Doctors About UnitedHealth's Medicare Billing Practices ...

In 1996, a gathering of master distillers revisited traditional whiskey-making wisdom from generations past. Nearly three ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content. For more information on individual ...

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory ...